Gadolinium deposition disease

Gadolinium deposition disease (GDD) is a condition where some people experience symptoms after receiving gadolinium-based contrast agents used in MRI scans. Gadolinium is a metal that helps make images clearer, but in certain individuals, small amounts may stay in the body longer than expected, potentially causing symptoms like pain, headaches, and fatigue. While the exact cause is still being studied, not everyone who gets a contrast agent develops GDD. Ongoing research aims to better understand how gadolinium behaves in the body and how to minimize risks.